IACCINO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 830
EU - Europa 495
AS - Asia 437
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Totale 1.768
Nazione #
US - Stati Uniti d'America 801
SG - Singapore 320
IT - Italia 313
CN - Cina 78
SE - Svezia 45
GB - Regno Unito 40
CA - Canada 29
DE - Germania 28
CZ - Repubblica Ceca 12
FR - Francia 11
HK - Hong Kong 11
FI - Finlandia 10
IN - India 10
KR - Corea 9
JP - Giappone 6
PL - Polonia 6
UA - Ucraina 6
NL - Olanda 5
RU - Federazione Russa 5
EE - Estonia 3
RO - Romania 3
AT - Austria 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
BD - Bangladesh 1
BR - Brasile 1
MN - Mongolia 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 1.768
Città #
Chandler 148
Singapore 138
Santa Clara 69
Catanzaro 63
Milan 53
Lawrence 43
Princeton 43
Ashburn 36
London 35
Chicago 29
Ottawa 27
Wilmington 21
Boardman 19
Napoli 16
Olomouc 12
Des Moines 10
Helsinki 10
Seattle 10
Shanghai 10
Hong Kong 9
Munich 9
Hanover 8
Los Angeles 7
Rome 7
Guangzhou 6
Padova 6
Augusta 5
Naples 5
Redmond 5
Seoul 5
Assago 4
Boston 4
Foggia 4
Latina 4
Luni 4
Norwalk 4
Paris 4
Providence 4
Beijing 3
Derby 3
Ferrara 3
Heiwajima 3
Huddinge 3
Jiaxing 3
Lamezia Terme 3
Novara 3
Redwood City 3
Reggio Calabria 3
San Francisco 3
Shenzhen 3
Treviso 3
Warsaw 3
Adrano 2
Auckland 2
Bagnara Calabra 2
Belgrade 2
Caserta 2
Chennai 2
Clearwater 2
Clifton 2
Cosenza 2
Dalmine 2
Dianzicheng 2
Edmonton 2
Gallipoli 2
Genoa 2
Lowell 2
Mapo-gu 2
Modena 2
Montalto Uffugo 2
Mugnano di Napoli 2
Nanchang 2
Pontedera 2
Portici 2
Pune 2
Romainville 2
San Nicola Manfredi 2
Songpa-gu 2
Timisoara 2
Torre Del Lago 2
Torre del Greco 2
Vibo Valentia 2
Washington 2
Wuhan 2
Athens 1
Aversa 1
Belgorod 1
Braga 1
Brecon 1
Brooklyn 1
Cagliari 1
Cava Dei Tirreni 1
Council Bluffs 1
Dalian 1
Dallas 1
Felgueiras 1
Fiumicino 1
Florence 1
Fremont 1
Fuzhou 1
Totale 1.018
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 99
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 67
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 54
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 51
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 45
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 44
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 43
The aftermath of the Merck's HIV vaccine trial 41
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 41
Collagen type V polymorphism in spontaneous quadriceps tendon ruptures 40
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 40
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 40
Kitcre knock-in mice fail to fate-map cardiac stem cells 39
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 37
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 37
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 36
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 36
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. 36
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 36
A novel phage display based platform for exosome diversity characterization 36
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 35
Cancer-associated CD43 glycoforms as target of immunotherapy 35
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 34
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 32
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 31
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 30
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 30
Phage Display: An Overview in Context to Drug Discovery 29
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 29
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 28
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 28
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 28
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 26
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 26
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 26
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 25
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 24
Insights into Thymus Development and Viral Thymic Infections 24
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 24
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 24
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 23
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 22
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing 20
Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study 20
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 20
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 20
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 19
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 18
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 18
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease 17
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 17
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study 16
Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease 16
Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's disease 16
Peptide-guided targeting of GPR55 for anti-cancer therapy 15
Belantamab mafodotin in multiple myeloma 14
Editorial: New perspectives on osteoclasts in health and disease 14
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 14
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 14
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 14
Elotuzumab in multiple myeloma 13
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 12
Isatuximab in multiple myeloma 11
null 10
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 8
null 6
Totale 1.873
Categoria #
all - tutte 22.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 0 0 0 0 0 0 0 0 9 36
2020/202195 4 6 2 4 7 1 12 2 31 19 0 7
2021/2022205 6 0 4 41 11 8 13 49 16 36 17 4
2022/2023482 89 35 30 22 44 39 13 30 86 27 50 17
2023/2024345 74 46 32 28 21 69 1 7 9 4 24 30
2024/2025640 126 36 47 27 88 98 23 19 141 35 0 0
Totale 1.873